Plasma BNP levels in the treatment of type 2 diabetes with pioglitazone.
J Clin Endocrinol Metab
; 88(8): 3993-6, 2003 Aug.
Article
em En
| MEDLINE
| ID: mdl-12915698
ABSTRACT
We monitored the change in plasma ANP and BNP levels (as markers for left ventricular dysfunction (LVD)) in DM2 patients treated with pioglitazone (Pio) for 4 weeks. Thirty DM2 patients with no sign of heart failure were treated with Pio (15 mg/day), and their plasma ANP (normal levels
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Tiazóis
/
Peptídeo Natriurético Encefálico
/
Tiazolidinedionas
/
Diabetes Mellitus Tipo 2
/
Hipoglicemiantes
Tipo de estudo:
Clinical_trials
/
Prognostic_studies
Limite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2003
Tipo de documento:
Article